Trial Profile
An Open-label, Randomized, Single-dose, 2×2 Crossover Study to Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual Tablets in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Oct 2014
Price :
$35
*
At a glance
- Drugs Amlodipine/fimasartan (Primary) ; Amlodipine; Fimasartan
- Indications Essential hypertension
- Focus Pharmacokinetics
- Sponsors Boryung Pharmaceutical
- 14 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 05 Aug 2014 New trial record